Details of the Drug

General Information of Drug (ID: DMFTKSI)

Drug Name

KDT-3594

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04867551) A Phase II Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease. U.S.National Institutes of Health.